Bioventus Inc.

BVS | NASDAQ

Price Alert Chart Builder DCF Calculator

$13.31

+$0.40 (+3.10%)

At close: Sep 21, 2026, 4:00 PM ET

$13.18

-$0.13 (-0.98%)

Pre-market: Sep 22, 2026, 7:43 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.10%

(1D)

Rating

Updated: Aug 28, 2026

Fundamentals Excellent

Market Sentiment Bullish

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $901.73M

1D Range

12.79 13.47

52W Range

6.26 15.89

Valuation (TTM)

PE 17.29

PB 3.95

EV/EBITDA 12.24

Valuation (NTM)

Forward PE 14.22

Forward PEG 0.91

Price Target $18.33

Cash Flow

FCF Yield 11.4%

SBC Adj. FCF Yield 9.4%

SBC Impact -17.7%

Margins

Gross Margin 68.0%

Operating Margin 10.6%

FCF Margin 17.6%

Growth (CAGR)

Revenue 3Y | 5Y 4.5% | 9.1%

Dil EPS 3Y | 5Y 2204.1% | 1.4%

FCF 3Y | 5Y 135.9% | 34.5%

Returns

ROA 8.1%

ROE 28.4%

ROIC 11.4%

Financial Health

Net Debt

$219M

Current Ratio 1.69

Interest Coverage 3.11

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain tre...

Sector Healthcare

Industry Medical - Devices

Employees 950

IPO Date Feb 10, 2021

Website www.bioventus.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 3, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$18

Upside

+35.24%

Buy (4)

Hold (0)

Sell (0)

Analyst Details ➞